Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 July 2020 | Story Amanda Thongha

Staff, students and other stakeholders of the University of the Free State (UFS) can look forward to a virtual music show honouring the values and beliefs of former President Nelson Mandela. Musicians such as Simple Stories, Sibongile Mngoma, Boitumelo Mohutsioa, and Lucy Sehloho have prepared performances that will be showcased on UFS communication platforms on 31 July. Concluding Mandela Month celebrations, the pre-recorded show will also feature performances by poets Braithan Moratwa and Zilungile Muqayi. The show is coordinated by the Division of Student Affairs at the UFS.  

Angelo Mockie, Senior Officer: Arts, Culture and Dialogue at Student Affairs, says the show was primarily produced to convey a message of hope, solidarity, and support to the UFS community. “We chose Mandela Month to publish it, because those are the values that he believed in. Now more than ever, we need to stand together as a community to find ways of adapting to the new normal.”

In a message to UFS staff acknowledging the life and legacy of Nelson Mandela, Prof Francis Petersen, Rector and Vice-Chancellor, said Madiba’s example of compassion and courage made him one of the best-known leaders in the world.
“His life was a true inspiration and his devotion to democracy, equality, learning, and caring for others have earned him the respect of communities around the world.

This year, the significance of Mandela Day will be even more important than ever before, as we demonstrate caring by looking after ourselves, our families, and those around us, while we navigate through the pandemic. Caring provides purpose, but also the motivation to fulfil that purpose. The COVID-19 pandemic should enable us to imagine a world that is fairer, safer, more stable, secure, and one that can prosper.”

Taking Action

Heeding the call to take action and inspire change on Nelson Mandela’s birthday, you can read the following articles about the UFS making every day a Mandela Day:

The shelter and the students – a triumph of social impact

South Campus delivers much-needed educational support during pandemic

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept